Citius Pharmaceuticals, Inc. Made Headway
Wed, Apr 01, 2020 at 05:30 PM
Citius Pharmaceuticals, Inc. (CTXR:NASDAQ) soared at $0.82, representing a gain of 36.6%. On Tue 31 Mar 20, CTXR:NASDAQ hit a New 2-Week Intraday High of $0.68. The stock appeared on our News Catalysts scanner on Wed 01 Apr 20 at 08:49 AM in the 'MISCELLANEOUS' category. From Tue 17 Mar 20, the stock recorded 70.00% Up Days and 27.27% Green Days
The stock spiked on Fri 17 Jan 20 at $1.45 with a volume of 3M+.
About Citius Pharmaceuticals, Inc. (CTXR:NASDAQ)
Citius Pharmaceuticals Inc is a specialty pharmaceutical company engaged in development and commercialization of therapeutic products for markets using patented or proprietary formulations and modified drug delivery technology.
Top 10 Gainers:
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 61.09%
- InflaRx N.V. (IFRX:NASDAQ), 50%
- Dynatronics Corporation (DYNT:NASDAQ), 48.2%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 43.41%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 42.38%
- Chembio Diagnostics, Inc. (CEMI:NASDAQ), 39.84%
- Citius Pharmaceuticals, Inc. (CTXR:NASDAQ), 36.64%
- Boxlight Corporation (BOXL:NASDAQ), 35.46%
- Safe-T Group Ltd (SFET:NASDAQ), 32.93%
- Athersys, Inc. (ATHX:NASDAQ), 32.67%